Adimab, LLC - Significant Ownership

Signature - Title
/s/ Philip Chase - Philip Chase, Chief Executive Officer
Location
Lebanon, NH
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Adimab, LLC.

Email me when Adimab, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Adimab, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
IVVD Invivyd, Inc. Common Stock, $0.0001 par value per share 8.8% $38.2M 20.5M Adimab, LLC Nov 17, 2025

Schedules 13D/G Reported by Adimab, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.